Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.85 USD | -0.52% | -5.87% | -9.84% |
May. 31 | Prelude Therapeutics Files for $400 Million Mixed Shelf | MT |
May. 07 | Prelude Therapeutics Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 211M |
---|---|---|---|---|---|
Net income 2024 * | -128M | Net income 2025 * | -138M | EV / Sales 2024 * | - |
Net cash position 2024 * | 201M | Net cash position 2025 * | 150M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.32
x | P/E ratio 2025 * |
-2.73
x | Employees | 128 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.93% |
Latest transcript on Prelude Therapeutics Incorporated
1 day | -0.52% | ||
1 week | -5.87% | ||
1 month | +3.22% | ||
3 months | -16.12% | ||
6 months | +19.38% | ||
Current year | -9.84% |
Managers | Title | Age | Since |
---|---|---|---|
Krishna Vaddi
FOU | Founder | 58 | 16-01-31 |
Bryant Lim
DFI | Director of Finance/CFO | 53 | 23-01-31 |
Jane Huang
PSD | President | 51 | 22-04-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Julian Baker
BRD | Director/Board Member | 57 | 21-01-24 |
Paul Friedman
CHM | Chairman | 81 | 16-06-30 |
David Bonita
BRD | Director/Board Member | 48 | 16-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 3.85 | -0.52% | 85,083 |
24-05-30 | 3.87 | +16.57% | 68,418 |
24-05-29 | 3.32 | -10.51% | 73,018 |
24-05-28 | 3.71 | -9.29% | 74,725 |
24-05-24 | 4.09 | +1.24% | 25,733 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.84% | 211M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- PRLD Stock